In: In Vitro Cellular & Developmental Biology - Animal, 2005, vol. 41, no. 7, p. 207-216
|
In: Clinical Infectious Diseases, 2018, vol. 66, no. 8, p. 1290–1297
The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern. Carbapenemase production is especially problematic when encountered in members of the family Enterobacteriaceae. Due to their ability to readily spread and colonize patients in healthcare environments, preventing the transmission of these organisms...
|
In: Health Policy and Planning, 2014, vol. 29, no. 5, p. 650-662
|
In: Journal of Antimicrobial Chemotherapy, 1995, vol. 35, no. 2, p. 345-348
|
In: Health Policy and Planning, 2005, vol. 20, no. 5, p. 290-301
|
In: Prehospital and Disaster Medicine, 2005, vol. 20, no. 6, p. 385-388
|
In: The Journal of Infectious Diseases, 2009, vol. 199, no. 7, p. 1053-1063
|
In: Epidemiology and Infection, 2013, vol. 141, no. 7, p. 1342-1356
|
In: Clinical Infectious Diseases, 2005, vol. 40, no. 2, p. 211-217
|
In: Clinical Infectious Diseases, 2006, vol. 42, no. 4, p. 490-497
|